Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies

The genetics of lymphoma susceptibility reflect the marked heterogeneity of diseases that comprise this broad phenotype. However, multiple subtypes of lymphoma are observed in some families, suggesting shared pathways of genetic predisposition to these pathologically distinct entities. Using a two-stage GWAS, we tested 530,583 SNPs in 944 cases of lymphoma, including 282 familial cases, and 4,044 public shared controls, followed by genotyping of 50 SNPs in 1,245 cases and 2,596 controls. A novel region on 11q12.1 showed association with combined lymphoma (LYM) subtypes. SNPs in this region included rs12289961 near LPXN, (PLYM = 3.89×10−8, OR = 1.29) and rs948562 (PLYM = 5.85×10−7, OR = 1.29). A SNP in a novel non-HLA region on 6p23 (rs707824, PNHL = 5.72×10−7) was suggestive of an association conferring susceptibility to lymphoma. Four SNPs, all in a previously reported HLA region, 6p21.32, showed genome-wide significant associations with follicular lymphoma. The most significant association with follicular lymphoma was for rs4530903 (PFL = 2.69×10−12, OR = 1.93). Three novel SNPs near the HLA locus, rs9268853, rs2647046, and rs2621416, demonstrated additional variation contributing toward genetic susceptibility to FL associated with this region. Genes implicated by GWAS were also found to be cis-eQTLs in lymphoblastoid cell lines; candidate genes in these regions have been implicated in hematopoiesis and immune function. These results, showing novel susceptibility regions and allelic heterogeneity, point to the existence of pathways of susceptibility to both shared as well as specific subtypes of lymphoid malignancy.

[1]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[2]  Hariklia Eleftherohorinou,et al.  Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. , 2011, Human molecular genetics.

[3]  A. Viale,et al.  Including Additional Controls from Public Databases Improves the Power of a Genome-Wide Association Study , 2011, Human Heredity.

[4]  Steven J. M. Jones,et al.  Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.

[5]  G. McVean,et al.  Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3. , 2011, Blood.

[6]  Raul Rabadan,et al.  Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.

[7]  Yusuke Nakamura,et al.  Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility , 2011, Journal of Human Genetics.

[8]  Peter Boyle,et al.  GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma , 2011, PLoS genetics.

[9]  A. Ashworth,et al.  A genome-wide association study of Hodgkin Lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21, and 10p14 (GATA3) , 2010, Nature Genetics.

[10]  Kenneth Offit,et al.  Genome-wide association studies of cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Peter Kraft,et al.  Quality control and quality assurance in genotypic data for genome‐wide association studies , 2010, Genetic epidemiology.

[12]  Tsun-Po Yang,et al.  Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies , 2010, Bioinform..

[13]  Kevin M. Brown,et al.  Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32 , 2010, Nature Genetics.

[14]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[15]  S. Orkin,et al.  Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells , 2009, Cell.

[16]  Ai-ping Li,et al.  LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation , 2009, Genes, chromosomes & cancer.

[17]  Wayne Tam,et al.  Reticuloendotheliosis Virus Strain T Induces miR-155, Which Targets JARID2 and Promotes Cell Survival , 2009, Journal of Virology.

[18]  P. Deloukas,et al.  Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner , 2009, Science.

[19]  Eran Halperin,et al.  Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma , 2009, Nature Genetics.

[20]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[21]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[22]  Joshua M. Korn,et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.

[23]  Philip S Rosenberg,et al.  PGA: power calculator for case-control genetic association analyses , 2008, BMC Genetics.

[24]  K. Lam,et al.  Leupaxin Negatively Regulates B Cell Receptor Signaling* , 2007, Journal of Biological Chemistry.

[25]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[26]  T. Takeuchi,et al.  Roles of jumonji and jumonji family genes in chromatin regulation and development , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[27]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[28]  E. Zintzaras,et al.  The risk of lymphoma development in autoimmune diseases: a meta-analysis. , 2005, Archives of internal medicine.

[29]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[30]  K. Offit,et al.  The genetics of familial lymphomas , 2004, Current oncology reports.

[31]  Stephen B. Johnson,et al.  The New York cancer project: Rationale, organization, design, and baseline characteristics , 2004, Journal of Urban Health.

[32]  M. Stovall,et al.  Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Sheila M. Thomas,et al.  Binding of paxillin to α4 integrins modifies integrin-dependent biological responses , 1999, Nature.

[34]  S. Pileri,et al.  From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  S. Wacholder,et al.  Second cancers among long-term survivors of non-Hodgkin's lymphoma. , 1993, Journal of the National Cancer Institute.

[36]  Tanya M. Teslovich,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[37]  W. Cao,et al.  CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. , 2005, The Biochemical journal.

[38]  Charles R Cantor,et al.  The use of MassARRAY technology for high throughput genotyping. , 2002, Advances in biochemical engineering/biotechnology.